Cargando…

Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres

Knowledge about the release behavior and drug retention properties of colloidal carriers is of essential importance for quality control as well as to predict in vivo performance. When conducting release studies from such systems, the release media should preferentially contain lipophilic acceptor co...

Descripción completa

Detalles Bibliográficos
Autores principales: Knoke, Sabrina, Bunjes, Heike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912624/
https://www.ncbi.nlm.nih.gov/pubmed/33525325
http://dx.doi.org/10.3390/pharmaceutics13020173
_version_ 1783656618481680384
author Knoke, Sabrina
Bunjes, Heike
author_facet Knoke, Sabrina
Bunjes, Heike
author_sort Knoke, Sabrina
collection PubMed
description Knowledge about the release behavior and drug retention properties of colloidal carriers is of essential importance for quality control as well as to predict in vivo performance. When conducting release studies from such systems, the release media should preferentially contain lipophilic acceptor components in order to mimic physiological conditions. In this study, transfer from a trimyristin nanoemulsion into lipid-containing hydrogel beads was investigated for fenofibrate, cannabidiol, retinyl acetate, orlistat, and lumefantrine. To generate the acceptor system, a trimyristin nanoemulsion was incorporated into Ca-alginate microspheres (mean diameter ~40 µm) with a spraying method. Using this approach, the advantages of small lipophilic acceptor particles with a large interfacial area were combined with a single separation process from the donor via a filtration step. The method was applicable to distinguish between fast (fenofibrate) and slow drug transfer (lumefantrine) with good time resolution. Lipophilicity, estimated according to the calculated logP value of the respective drug, was a major factor influencing the transfer performance: the higher the logP value, the slower the transfer. This experimental setup is a promising technique to investigate the release of poorly water-soluble drugs from various types of nanocarriers under closer to physiological conditions than with many other methods currently applied.
format Online
Article
Text
id pubmed-7912624
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79126242021-02-28 Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres Knoke, Sabrina Bunjes, Heike Pharmaceutics Article Knowledge about the release behavior and drug retention properties of colloidal carriers is of essential importance for quality control as well as to predict in vivo performance. When conducting release studies from such systems, the release media should preferentially contain lipophilic acceptor components in order to mimic physiological conditions. In this study, transfer from a trimyristin nanoemulsion into lipid-containing hydrogel beads was investigated for fenofibrate, cannabidiol, retinyl acetate, orlistat, and lumefantrine. To generate the acceptor system, a trimyristin nanoemulsion was incorporated into Ca-alginate microspheres (mean diameter ~40 µm) with a spraying method. Using this approach, the advantages of small lipophilic acceptor particles with a large interfacial area were combined with a single separation process from the donor via a filtration step. The method was applicable to distinguish between fast (fenofibrate) and slow drug transfer (lumefantrine) with good time resolution. Lipophilicity, estimated according to the calculated logP value of the respective drug, was a major factor influencing the transfer performance: the higher the logP value, the slower the transfer. This experimental setup is a promising technique to investigate the release of poorly water-soluble drugs from various types of nanocarriers under closer to physiological conditions than with many other methods currently applied. MDPI 2021-01-28 /pmc/articles/PMC7912624/ /pubmed/33525325 http://dx.doi.org/10.3390/pharmaceutics13020173 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Knoke, Sabrina
Bunjes, Heike
Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres
title Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres
title_full Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres
title_fullStr Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres
title_full_unstemmed Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres
title_short Transfer of Lipophilic Drugs from Nanoemulsions into Lipid-Containing Alginate Microspheres
title_sort transfer of lipophilic drugs from nanoemulsions into lipid-containing alginate microspheres
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912624/
https://www.ncbi.nlm.nih.gov/pubmed/33525325
http://dx.doi.org/10.3390/pharmaceutics13020173
work_keys_str_mv AT knokesabrina transferoflipophilicdrugsfromnanoemulsionsintolipidcontainingalginatemicrospheres
AT bunjesheike transferoflipophilicdrugsfromnanoemulsionsintolipidcontainingalginatemicrospheres